CLTA-4 blockade in vivo promotes the generation of short-lived effector CD8+ T cells and a more persistent central memory CD4+ T cell response

    loading  Checking for direct PDF access through Ovid



Previously, we examined the effects of in vivo CTLA-4 blockade using a fully human monoclonal antibody as a part of a DNA vaccination regimen in cynomolgus macaques (Macaca fascicularis). We observed that while the antibody had little effect on the IFN-γ ELISpot response, CTLA-4 blockade enhanced antigen-specific cellular proliferation in both CD4+ and CD8+T-cell compartments.


We examine the specific effects of CTLA-4 blockade on memory T-cell compartments following the third immunization and 10 months following a fourth immunization, during the memory phase of the immune response.


CLTA-4 blockade enhanced CD4+ and CD8+ central memory (CD28hi, CD95hi) T-cell responses as well as a short-lived CD8+ effector (CD28lo, CD95hi) T-cell response.


These data suggest differing effects of CTLA-4 blockade on CD4+ and CD8+ T cells with implications on the clinical use of anti-CTLA-4 antibodies for enhancement of vaccine strategies or treatment of human disease.

Related Topics

    loading  Loading Related Articles